Erselcan, T., Kairemo, K. J. A., Wiklund, T. A., Hernberg, M., Blomqvist, C. P., Tenhunen, M., . . . Joensuu, H. (2000). Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer. Nature Publishing Group.

Erselcan, T., K J A. Kairemo, T A. Wiklund, M. Hernberg, C P. Blomqvist, M. Tenhunen, J. Bergh, and H. Joensuu. Subclinical Cardiotoxicity Following Adjuvant Dose-escalated FEC, High-dose Chemotherapy, or CMF in Breast Cancer. Nature Publishing Group, 2000.

Erselcan, T., et al. Subclinical Cardiotoxicity Following Adjuvant Dose-escalated FEC, High-dose Chemotherapy, or CMF in Breast Cancer. Nature Publishing Group, 2000.